ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,175Medicare Part D Prescriptions Filled, Including Refills

Rank: 45 out of 387

$800K Total Retail Price of All Prescriptions

Rank: 49 out of 387

584 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
4% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 584 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

10% of this provider’s 584 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

3% of this provider’s 13,627 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
SIMVASTATIN 675 659 1 5
LEVOTHYROXINE SODIUM 514 493 2 2
ENALAPRIL MALEATE 464 452 3 69
AMLODIPINE BESYLATE 393 393 4 6
CARVEDILOL 357 351 5 21
FUROSEMIDE 336 325 6 7
METFORMIN HCL 315 296 7 8
METOPROLOL SUCCINATE 294 293 8 18
POTASSIUM CHLORIDE 263 262 9 9
OMEPRAZOLE 258 253 10 4
HYDROCODONE-ACETAMINOPHEN 254 250 S3 11 1
ATORVASTATIN CALCIUM 246 244 12 13
HYDROCHLOROTHIAZIDE 244 240 13 12
ZOLPIDEM TARTRATE 243 225 14 16
DIOVAN 243 243 14 33
METOPROLOL TARTRATE 234 233 16 11
WARFARIN SODIUM 229 208 17 17
PRAVASTATIN SODIUM 213 212 18 15
LISINOPRIL 202 199 19 3
CRESTOR 199 186 20 34
GABAPENTIN 180 169 21 10
SERTRALINE HCL 164 155 22 23
SYNTHROID 163 134 23 68
TRAMADOL HCL 160 146 24 14
KLOR-CON 10 152 148 25 124
ATENOLOL 141 141 26 20
CLOPIDOGREL 126 125 27 25
BISOPROLOL FUMARATE 123 117 28 252
PREMARIN 117 117 R 29 77
LISINOPRIL-HYDROCHLOROTHIAZIDE 117 117 29 30
PANTOPRAZOLE SODIUM 116 116 31 48
ALLOPURINOL 111 111 32 28
TAMSULOSIN HCL 107 102 33 32
TRIAMTERENE-HCTZ 104 97 34 55
DIGOXIN 104 104 34 40
GLIMEPIRIDE 103 98 36 50
VERAPAMIL ER 101 101 37 87
TRAZODONE HCL 101 86 37 37
PLAVIX 100 100 39 39
JANUVIA 100 93 39 60
ISOSORBIDE MONONITRATE ER 89 89 41 59
LOVASTATIN 84 79 42 36
MELOXICAM 80 78 43 22
AMLODIPINE BESYLATE-BENAZEPRIL 77 77 44 54
DOXAZOSIN MESYLATE 76 74 45 75
AZITHROMYCIN 75 68 46 49
BISOPROLOL-HYDROCHLOROTHIAZIDE 74 72 47 144
FLUOXETINE HCL 74 61 47 46
FLUTICASONE PROPIONATE 73 70 49 29
RAMIPRIL 72 72 50 119
PROPRANOLOL HCL 69 61 51 100
NABUMETONE 66 62 52 117
HYDRALAZINE HCL 65 65 53 94
CIPROFLOXACIN HCL 62 62 54 56
LOSARTAN POTASSIUM 62 62 54 24
NEXIUM 61 59 56 26
CLONIDINE HCL 60 60 57 38
DICLOFENAC SODIUM 58 58 58 115
COUMADIN 56 56 59 239
FENTANYL 56 56 S2 59 80
PREDNISONE 55 55 61 43
BENAZEPRIL HCL 52 52 62 86
LOSARTAN-HYDROCHLOROTHIAZIDE 51 48 63 65
CELEBREX 50 49 64 72
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 28, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.